Exciting news from Japan! The Ministry of Health, Labour and Welfare (MHLW) has officially approved Sarepta Therapeutics’ groundbreaking gene therapy for Duchenne muscular dystrophy (DMD). This pivotal decision opens up new horizons for patients in Japan battling this challenging condition, offering hope and enhanced treatment options like never before.
Spain’s antitrust authority is on the brink of greenlighting BBVA’s acquisition of Sabadell, but not without some necessary adjustments, according to insider sources. This pivotal approval has the potential to transform the Spanish banking scene, paving the way for greater consolidation in response to mounting competitive challenges.
Italy’s antitrust authority has granted conditional approval for Italgas’ acquisition of 2i Rete Gas, a significant move aimed at enhancing the country’s gas distribution network. The decision underscores ongoing efforts to promote competition in the energy sector.
BBVA has received regulatory approval to offer cryptocurrency services in Spain, marking a significant step in the bank’s digital strategy. This move underscores the growing acceptance of digital currencies within traditional banking frameworks.
bioMérieux has announced that it has received Health Canada approval for its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel. This diagnostic tool aims to enhance rapid testing for respiratory infections, providing efficient solutions for patient care in Canada.
